Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-12-08

Clinical Trial Update: A Pilot Study on Effect of add-on Sulforaphane to SSRIs and Application of Niacin Skin Flush Response Test in Major Depressive Disorder [Phase 4]

View source ↗

Summary

Pilot Phase 4 study examining add-on sulforaphane to SSRIs with niacin skin flush test in major depressive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SSRIs (selective serotonin reuptake inhibitors)
  • Sulforaphane (add-on) (sulforaphane)

Snippet

Sponsor: Shanghai Mental Health Center | Conditions: Major Depressive Disorder | Phase 4 | Status: UNKNOWN